Compare VAC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VAC | NEO |
|---|---|---|
| Founded | 1984 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 1999 |
| Metric | VAC | NEO |
|---|---|---|
| Price | $59.06 | $12.99 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $63.38 | $11.38 |
| AVG Volume (30 Days) | 532.4K | ★ 2.0M |
| Earning Date | 02-25-2026 | 02-17-2026 |
| Dividend Yield | ★ 5.43% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.58 | N/A |
| Revenue | ★ $3,358,000,000.00 | $709,162,000.00 |
| Revenue This Year | $54.51 | $10.90 |
| Revenue Next Year | $2.59 | $9.85 |
| P/E Ratio | $12.88 | ★ N/A |
| Revenue Growth | 5.13 | ★ 10.10 |
| 52 Week Low | $44.58 | $4.72 |
| 52 Week High | $91.18 | $15.32 |
| Indicator | VAC | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 58.04 |
| Support Level | $57.55 | $12.29 |
| Resistance Level | $65.45 | $13.29 |
| Average True Range (ATR) | 2.30 | 0.65 |
| MACD | -0.55 | -0.03 |
| Stochastic Oscillator | 21.63 | 63.23 |
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.